# Efficacy of Remote Monitoring of Patients With Heart Failure and Reduced Ejection Fraction by Using Caaring® Software

Study · id `cardio:ct-nct06920160` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06920160](<https://clinicaltrials.gov/study/NCT06920160>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06920160

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 196 participants.

## Technical summary

Registry record NCT06920160. Randomized; no masking; primary purpose other. Start 2025-04-15 (actual); primary completion 2025-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 196 participants (planned count; ClinicalTrials.gov record NCT06920160, source copy `cardio:ctgov-nct06920160-2025-06-04`, retrieved 2026-10-26)
- Started: 2025-04-15 (actual) (ClinicalTrials.gov record NCT06920160, source copy `cardio:ctgov-nct06920160-2025-06-04`, retrieved 2026-10-26)
- Primary completion: 2025-07 (anticipated) (ClinicalTrials.gov record NCT06920160, source copy `cardio:ctgov-nct06920160-2025-06-04`, retrieved 2026-10-26)
- Completion: 2025-08 (anticipated) (ClinicalTrials.gov record NCT06920160, source copy `cardio:ctgov-nct06920160-2025-06-04`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT06920160, source copy `cardio:ctgov-nct06920160-2025-06-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06920160-2025-06-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Remote Monitoring of Patients With Heart Failure and Reduced Ejection Fraction by Using Caaring® Software
- Acronym: (CAARdioRING)
- Condition: Heart Failure With Reduced Ejection Fraction
- Intervention (Device): software Caaring (remote monitoring app)
- Lead sponsor: Persei Vivarium
- Lead sponsor class: OTHER
- Collaborator: Effice Servicios Para la Investigacion S.L.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 6a25999d62555e95fba43863b5a6bccf91e126217d523e6f12bf26837d6539ca
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
